The Saskatchewan and federal governments have announced an agreement for coverage of select new drugs for rare diseases.
Ottawa says the plan is to invest more than $40 million to cover three drugs that treat certain cancers and a urinary issue.
The medicines are Poteligeo, Oxlumo and Epkinly.
The agreement is to also see Saskatchewan work with Ottawa and other provinces to develop a plan to improve screening and diagnostics for rare diseases.
Federal Health Minister Mark Holland says the deal helps the health system improve outcomes for those in Saskatchewan with rare diseases.
